Abstract
Background: Globally, multiple million of the population is suffering from diabetes mellitus (DM), which follows chronic course. As the report published by World Health Organization (WHO), number of cases of DM have risen massively by 4 times in 2014, as compared to 3 decades prior period. Comprehensive diabetes care program (CDC) is an Ayurvedic form of therapy which consists of management of T2DM by Panchkarma, diet therapy.
Aims and objectives: The present study was planned to analyze the effectiveness of CDC on blood glucose parameters in patient of T2DM.
Materials and methods: This observational study was conducted from November 2018 to October 2019, wherein the data of type 2 DM patients (HbA1c >6%) who attended out-patient departments (OPDs) at Madhavbaug clinics across central Mumbai were identified. Data of patients who were administered CDC (60-75 minutes) with minimum 6 sittings over 12 weeks were considered. All the glycemic parameters were compared at baseline and week 12.
Results: In the present study, out of 424 type 2 diabetic patients and borderline cases, 225 were males (52%), while 199 were females (48%), thus male: female ratio was 1.13:1. The number of patients with controlled DM status rose from zero at baseline to 215 (51%) at week 12 of CDC therapy. All the anthropometric parameters, lipid parameters, etc., showed statistically significant improvement, and reduction in dependency on allopathic medications at week 12 of CDC therapy.
Conclusion: From the findings of the present study, it was clear that CDC improved two most critical parameters- reduction in HbA1c and patient’s dependency on conventional medicines, which helps to reduce cost of therapy and thus improve patient compliance.
Locate a Centre
